BAP1 loss defines a new class of renal cell carcinoma
暂无分享,去创建一个
N. Grishin | D. Bentley | M. Ross | C. Haudenschild | M. Laurent | A. Liao | P. Kapur | J. Brugarolas | S. Peña-Llopis | S. Vega-Rubín-de-Celis | Nan Leng | Andrea Pavía-Jiménez | Shanshan Wang | T. Yamasaki | Leah Zhrebker | S. Sivanand | Patrick Spence | L. Kinch | T. Hambuch | Suneer Jain | Y. Lotan | V. Margulis | A. Sagalowsky | P. Summerour | Wareef Kabbani | S. W. Wong | Xian-Jin Xie | Payal Kapur | S. Wong | Toshinari Yamasaki
[1] M. Karno,et al. Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.
[2] J. H. Steiger. Tests for comparing elements of a correlation matrix. , 1980 .
[3] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.
[4] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[5] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.
[6] R. Spritz,et al. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. , 1994, The New England journal of medicine.
[7] J. Brooks,et al. Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.
[8] Christian Coulange,et al. Prognostic value of nuclear grade of renal cell carcinoma , 1995, Cancer.
[9] R. Hruban,et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.
[10] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[11] Keith D Wilkinson,et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.
[12] Patrick T. Reilly,et al. Loss of HCF-1–Chromatin Association Precedes Temperature-Induced Growth Arrest of tsBN67 Cells , 2001, Molecular and Cellular Biology.
[13] H. Shimizu,et al. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients. , 2003, The Journal of investigative dermatology.
[14] W. Herr,et al. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. , 2003, Genes & development.
[15] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[16] W. Herr,et al. Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression , 2004, Molecular and Cellular Biology.
[17] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[18] William Arbuthnot Sir Lane,et al. A Human Protein Complex Homologous to the Drosophila MSL Complex Is Responsible for the Majority of Histone H4 Acetylation at Lysine 16 , 2005, Molecular and Cellular Biology.
[19] William Arbuthnot Sir Lane,et al. A Human Protein Complex Homologous to the Drosophila MSL Complex Is Responsible for the Majority of Histone H4 Acetylation at Lysine 16 , 2006, Molecular and Cellular Biology.
[20] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[21] J. Capone,et al. Host Cell Factor-1 and E2F4 Interact Via Multiple Determinants in Each Protein , 2006, Molecular and Cellular Biochemistry.
[22] Torsten Schwede,et al. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling , 2006, Bioinform..
[23] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[24] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[25] B. A. Ballif,et al. ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.
[26] Winship Herr,et al. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. , 2007, Molecular cell.
[27] C. Allis,et al. Extraction, purification and analysis of histones , 2007, Nature Protocols.
[28] Aarthi Narayanan,et al. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection , 2007, Proceedings of the National Academy of Sciences.
[29] David B Seligson,et al. Prognostic relevance of the mTOR pathway in renal cell carcinoma , 2007, Cancer.
[30] James Brugarolas,et al. Renal-cell carcinoma--molecular pathways and therapies. , 2007, The New England journal of medicine.
[31] S. Gygi,et al. Profiling of UV-induced ATM/ATR signaling pathways , 2007, Proceedings of the National Academy of Sciences.
[32] Erwin G. Van Meir,et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. , 2008, Cancer research.
[33] Nancy F. Hansen,et al. Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.
[34] M. van Engeland,et al. Genetics and epigenetics of renal cell cancer. , 2008, Biochimica et biophysica acta.
[35] F. Waldman,et al. Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors , 2008, Clinical Cancer Research.
[36] Anindya Dutta,et al. The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1* , 2009, The Journal of Biological Chemistry.
[37] Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1 , 2009, Molecular and Cellular Biology.
[38] Johannes Söding,et al. Fast and accurate automatic structure prediction with HHpred , 2009, Proteins.
[39] Arianna Di Napoli,et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. , 2009, Cancer research.
[40] J. Gu,et al. Genome‐wide profiling of chromosomal alterations in renal cell carcinoma using high‐density single nucleotide polymorphism arrays , 2009, International journal of cancer.
[41] Bin Tean Teh,et al. Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer , 2009, Nature Genetics.
[42] T. Ohta,et al. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. , 2009, Cancer research.
[43] Yu Liang,et al. Inhibition of the histone demethylase LSD1 blocks α-herpesvirus lytic replication and reactivation from latency , 2009, Nature Medicine.
[44] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[45] M. Wilm,et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB , 2010, Nature.
[46] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[47] T. Kristie,et al. Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities. , 2010, Biochimica et biophysica acta.
[48] R. Montironi,et al. Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. , 2010, European urology.
[49] N. Grishin,et al. Structural analysis and functional implications of the negative mTORC1 regulator REDD1. , 2010, Biochemistry.
[50] G. Hart,et al. The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression , 2010, Molecular and Cellular Biology.
[51] C. Sander,et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma , 2011, Nature Genetics.
[52] R. Leveillee,et al. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma. , 2011, Annals of diagnostic pathology.
[53] P. Humphrey,et al. Renal Cell Carcinoma With Rhabdoid Features , 2000, The Journal of urology.
[54] J. Brugarolas,et al. Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma , 2011, Molecular Cancer Research.
[55] Ziad M. Eletr,et al. An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression , 2011, Cell Biochemistry and Biophysics.
[56] P. A. Futreal,et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.
[57] M. Abdel-Rahman,et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers , 2011, Journal of Medical Genetics.
[58] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[59] T. Milman,et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2011 .
[60] A. Porcelli,et al. Learning from oncocytic tumors: Why choose inefficient mitochondria? , 2011, Biochimica et biophysica acta.
[61] J. Becker,et al. Germline mutations in BAP1 predispose to melanocytic tumors , 2011, Nature Genetics.
[62] D. Corey,et al. Regulation of TFEB and V-ATPases by mTORC1 , 2011, The EMBO journal.
[63] N. Cox,et al. Germline BAP1 mutations predispose to malignant mesothelioma , 2011, Nature Genetics.
[64] W. Kaelin. Molecular Biology of Clear Cell Renal Carcinoma , 2012 .
[65] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[66] Huanming Yang,et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma , 2011, Nature Genetics.
[67] R. Arceci. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .
[68] J. Brugarolas. Research Translation and Personalized Medicine , 2012 .
[69] D. Bentley,et al. A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma , 2012, Science Translational Medicine.